CLSD
Price
$0.90
Change
-$0.03 (-3.23%)
Updated
Apr 3, 02:33 PM (EDT)
Capitalization
71.74M
35 days until earnings call
VCYT
Price
$28.55
Change
-$1.58 (-5.24%)
Updated
Apr 3, 03:02 PM (EDT)
Capitalization
1.66B
40 days until earnings call
Ad is loading...

CLSD vs VCYT

Header iconCLSD vs VCYT Comparison
Open Charts CLSD vs VCYTBanner chart's image
Clearside Biomedical
Price$0.90
Change-$0.03 (-3.23%)
Volume$742
Capitalization71.74M
Veracyte
Price$28.55
Change-$1.58 (-5.24%)
Volume$400
Capitalization1.66B
CLSD vs VCYT Comparison Chart
Loading...
CLSD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VCYT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CLSD vs. VCYT commentary
Apr 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLSD is a StrongBuy and VCYT is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 03, 2025
Stock price -- (CLSD: $0.93 vs. VCYT: $30.13)
Brand notoriety: CLSD and VCYT are both not notable
CLSD represents the Biotechnology, while VCYT is part of the Medical Specialties industry
Current volume relative to the 65-day Moving Average: CLSD: 29% vs. VCYT: 85%
Market capitalization -- CLSD: $71.74M vs. VCYT: $1.66B
CLSD [@Biotechnology] is valued at $71.74M. VCYT’s [@Medical Specialties] market capitalization is $1.66B. The market cap for tickers in the [@Biotechnology] industry ranges from $308.32B to $0. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B. The average market capitalization across the [@Medical Specialties] industry is $8.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLSD’s FA Score shows that 0 FA rating(s) are green whileVCYT’s FA Score has 0 green FA rating(s).

  • CLSD’s FA Score: 0 green, 5 red.
  • VCYT’s FA Score: 0 green, 5 red.
According to our system of comparison, VCYT is a better buy in the long-term than CLSD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLSD’s TA Score shows that 5 TA indicator(s) are bullish while VCYT’s TA Score has 4 bullish TA indicator(s).

  • CLSD’s TA Score: 5 bullish, 4 bearish.
  • VCYT’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, CLSD is a better buy in the short-term than VCYT.

Price Growth

CLSD (@Biotechnology) experienced а -8.82% price change this week, while VCYT (@Medical Specialties) price change was -2.96% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.39%. For the same industry, the average monthly price growth was -10.40%, and the average quarterly price growth was -14.52%.

The average weekly price growth across all stocks in the @Medical Specialties industry was -3.77%. For the same industry, the average monthly price growth was +2.20%, and the average quarterly price growth was +1.95%.

Reported Earning Dates

CLSD is expected to report earnings on May 08, 2025.

VCYT is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Biotechnology (-8.39% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

@Medical Specialties (-3.77% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VCYT($1.66B) has a higher market cap than CLSD($71.7M). CLSD YTD gains are higher at: -2.105 vs. VCYT (-23.914). CLSD has higher annual earnings (EBITDA): -22.23M vs. VCYT (-49.41M). VCYT has more cash in the bank: 216M vs. CLSD (23.6M). CLSD has less debt than VCYT: CLSD (785K) vs VCYT (12.6M). VCYT has higher revenues than CLSD: VCYT (361M) vs CLSD (7.7M).
CLSDVCYTCLSD / VCYT
Capitalization71.7M1.66B4%
EBITDA-22.23M-49.41M45%
Gain YTD-2.105-23.9149%
P/E RatioN/AN/A-
Revenue7.7M361M2%
Total Cash23.6M216M11%
Total Debt785K12.6M6%
FUNDAMENTALS RATINGS
CLSD vs VCYT: Fundamental Ratings
CLSD
VCYT
OUTLOOK RATING
1..100
245
VALUATION
overvalued / fair valued / undervalued
1..100
90
Overvalued
82
Overvalued
PROFIT vs RISK RATING
1..100
10087
SMR RATING
1..100
10088
PRICE GROWTH RATING
1..100
6262
P/E GROWTH RATING
1..100
7659
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VCYT's Valuation (82) in the Biotechnology industry is in the same range as CLSD (90) in the Pharmaceuticals Major industry. This means that VCYT’s stock grew similarly to CLSD’s over the last 12 months.

VCYT's Profit vs Risk Rating (87) in the Biotechnology industry is in the same range as CLSD (100) in the Pharmaceuticals Major industry. This means that VCYT’s stock grew similarly to CLSD’s over the last 12 months.

VCYT's SMR Rating (88) in the Biotechnology industry is in the same range as CLSD (100) in the Pharmaceuticals Major industry. This means that VCYT’s stock grew similarly to CLSD’s over the last 12 months.

VCYT's Price Growth Rating (62) in the Biotechnology industry is in the same range as CLSD (62) in the Pharmaceuticals Major industry. This means that VCYT’s stock grew similarly to CLSD’s over the last 12 months.

VCYT's P/E Growth Rating (59) in the Biotechnology industry is in the same range as CLSD (76) in the Pharmaceuticals Major industry. This means that VCYT’s stock grew similarly to CLSD’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CLSDVCYT
RSI
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
82%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
77%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 8 days ago
82%
Bullish Trend 10 days ago
76%
Declines
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
81%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
86%
Aroon
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
86%
View a ticker or compare two or three
Ad is loading...
CLSD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VCYT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FTCI2.950.20
+7.27%
FTC Solar
ORCL145.863.92
+2.76%
Oracle Corp
DQ18.150.03
+0.17%
Daqo New Energy Corp
INGR135.32-0.64
-0.47%
Ingredion
MLP17.38-0.20
-1.14%
Maui Land & Pineapple Co

CLSD and

Correlation & Price change

A.I.dvisor tells us that CLSD and INBX have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CLSD and INBX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLSD
1D Price
Change %
CLSD100%
+2.47%
INBX - CLSD
28%
Poorly correlated
+0.36%
IKNA - CLSD
27%
Poorly correlated
N/A
VCYT - CLSD
27%
Poorly correlated
+1.93%
NXTC - CLSD
25%
Poorly correlated
-8.47%
FBIO - CLSD
25%
Poorly correlated
+4.55%
More

VCYT and

Correlation & Price change

A.I.dvisor indicates that over the last year, VCYT has been closely correlated with NTLA. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if VCYT jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VCYT
1D Price
Change %
VCYT100%
+1.93%
NTLA - VCYT
69%
Closely correlated
+9.69%
VCEL - VCYT
60%
Loosely correlated
+2.84%
AXON - VCYT
58%
Loosely correlated
+3.18%
DNA - VCYT
57%
Loosely correlated
+5.30%
ABCL - VCYT
55%
Loosely correlated
+6.22%
More